MedPath

G-Tech Feasibility Study for Early Detection of a Post-op Ileus

Recruiting
Conditions
Post-operative Ileus
Registration Number
NCT02673671
Lead Sponsor
G-Tech Corporation
Brief Summary

This feasibility study is for the purpose of determining if the G-Tech Device can differentiate between normal return of GI activity post-operatively and the myoelectric activity in patients who develop a POI.

Detailed Description

While preventing the development of a POI is most important, POIs still occur; therefore, it is important to definitively diagnose a POI as early as possible during the post-operative course for treatment to prevent patient discomfort, complications, and extended hospital stay. The purpose of the G-Tech study is to determine if the G-Tech Device can detect a difference in the myoelectric signals from patients who develop a POI compared to those patients who do not develop a POI. It is anticipated that up to 20% of patients enrolled in this study and consented preoperatively, excluding screen failures, will show evidence of a post-operative ileus as detected by the G-Tech GutCheck Device and differentiate the myoelectric signals from the patients who do not develop a POI. Patients who are known to have developed a POI may also be selected for the study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  1. Willing and able to provide informed consent;
  2. Eighteen (18) years of age or older;
  3. Subject is willing and able to follow all study requirements;
  4. Subject who will undergo or has undergone open or laparoscopic gastrointestinal surgery or surgery not involving the abdominal cavity.
Exclusion Criteria
  1. Subject is pregnant or suspects pregnancy;
  2. Known allergy to medical grade adhesive;
  3. Weight > 350 lbs (159 Kg);

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Myoelectric activity pattern in POI patients versus non-POI patientsUp to 6 Days

The resumption of motor activity in the stomach, small intestine, and colon post-operatively. The measurement is myoelectric signals measured at the skin surface similar to ECG recordings for the heart

Secondary Outcome Measures
NameTimeMethod
Anticipated Adverse EventsUp to 6 days

Device related anticipated adverse events; such as, skin irritation due to adhesive from the skin patch.

Device SuccessUp to 6 Days

Device success defined as the ability to record GI myoelectric activity following GI surgery.

UADEsUp to 6 Days

Unanticipated adverse device effects

Trial Locations

Locations (1)

El Camino Hospital

🇺🇸

Mountain View, California, United States

El Camino Hospital
🇺🇸Mountain View, California, United States
Steve Axelrod, PhD
Contact
650-269-1479
steve.axelrod@gtechhealth.com
Anand Navalgund, PhD
Contact
614-886-7789
anand.navalgund@gtechhealth.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.